Clinicopathologic characteristics and treatment outcome of the addition of rituximab to chemotherapy for CD 5-positive in comparison with CD 5-negative diffuse large B-cell lymphoma
暂无分享,去创建一个
H. Nakamine | K. Ohshima | T. Yoshino | S. Nakamura | N. Nakamura | N. Niitsu | J. Tamaru | M. Hirano | M. Okamoto